Member of the Association of American Physicians
His scientific interests lie mostly in Cell biology, Transcription factor, Molecular biology, Immunology and Megakaryocyte. His Cell biology research includes themes of Platelet and Endocrinology. His work deals with themes such as NFE2 and NF-E2 Transcription Factor, which intersect with Endocrinology.
His studies in Transcription factor integrate themes in fields like Regulation of gene expression and Cellular differentiation. The various areas that Ramesh A. Shivdasani examines in his Immunology study include Progenitor cell and Cell. The study incorporates disciplines such as Knockout mouse, Cytoskeleton and Actin in addition to Megakaryocyte.
Ramesh A. Shivdasani spends much of his time researching Cell biology, Transcription factor, Cellular differentiation, Molecular biology and Genetics. Ramesh A. Shivdasani focuses mostly in the field of Cell biology, narrowing it down to topics relating to Platelet and, in certain cases, Microtubule. Ramesh A. Shivdasani has researched Transcription factor in several fields, including Chromatin and Regulation of gene expression.
His Cellular differentiation research is multidisciplinary, incorporating elements of Pathology, Intestinal mucosa and Gene expression, Transcriptional regulation. The concepts of his Thrombopoiesis study are interwoven with issues in Signal transduction, Immunology and Cytoskeleton. His study in Megakaryocyte is interdisciplinary in nature, drawing from both Endocrinology, Thrombopoietin and Internal medicine.
Ramesh A. Shivdasani mainly focuses on Cell biology, Transcription factor, Gene, Chromatin and Stem cell. His research in Cell biology intersects with topics in Cell, Cell type, Histone and Cellular differentiation. His Transcription factor research includes elements of Regulation of gene expression, Bioinformatics and Cancer research.
His Cancer research study combines topics in areas such as Carcinogenesis and Colorectal cancer. His research integrates issues of Embryonic stem cell, Gene silencing and Cell fate determination in his study of Chromatin. His Stem cell research focuses on Wnt signaling pathway and how it relates to Mesenchyme.
His main research concerns Transcription factor, Stem cell, Cell biology, Enhancer and Gene. Transcription factor is a primary field of his research addressed under Genetics. His Cell biology research incorporates elements of Cell and Epithelium.
His Epithelium research is multidisciplinary, incorporating perspectives in Internal medicine, Insulin and Endocrinology. His research on Enhancer also deals with topics like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Aleksandar D. Kostic;Dirk Gevers;Chandra Sekhar Pedamallu;Chandra Sekhar Pedamallu;Monia Michaud.
Genome Research (2012)
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL.
Ramesh A. Shivdasani;Erica L. Mayer;Erica L. Mayer;Stuart H. Orkin;Stuart H. Orkin.
SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas
Adam J. Bass;Adam J. Bass;Hideo Watanabe;Hideo Watanabe;Craig H. Mermel;Craig H. Mermel;Soyoung Yu.
Nature Genetics (2009)
The transcriptional control of hematopoiesis.
Ramesh A. Shivdasani;Stuart H. Orkin.
Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.
Ramesh A Shivdasani;Margery F Rosenblatt;Dorothea Zucker-Franklin;Carl W Jackson.
A lineage‐selective knockout establishes the critical role of transcription factor GATA‐1 in megakaryocyte growth and platelet development
Ramesh A. Shivdasani;Yuko Fujiwara;Yuko Fujiwara;Yuko Fujiwara;Michael A. McDevitt;Stuart H. Orkin.
The EMBO Journal (1997)
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Maina Lepourcelet;Ying-Nan P. Chen;Huisheng Wang.
Cancer Cell (2004)
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
Mark M. Pomerantz;Nasim Ahmadiyeh;Nasim Ahmadiyeh;Li Jia;Paula Herman.
Nature Genetics (2009)
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
Tobias Junt;Harald Schulze;Zhao Chen;Steffen Massberg.
CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
Ron Firestein;Adam Bass;So Young Kim;Ian Frederick Dunn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: